Bacterial Infections in End-Stage Liver Disease: Implications for Liver Transplantation

Bacterial infections are a common complication in patients with decompensated liver cirrhosis. The complex landscape of cirrhosis, characterized by immune paralysis and an exhausted response to exogenous triggers, explains the higher prevalence of such infections, particularly in advanced disease stages. In clinical practice, the onset of a bacterial infection can lead to further deterioration of hepatic and extra-hepatic function, potentially resulting in acute decompensation or acute-on-chronic liver failure. This has significant clinical implications, particularly for patients awaiting a transplant. In this review, we will discuss the latest evidence on the diagnosis and therapy of bacterial infections in patients with decompensated cirrhosis. Additionally, we will analyze the impact of bacterial infections in the context of liver transplantation, discussing debated topics such as the timing of transplantation in patients with infections, potential implications for prioritization, effects on post-operative recovery, grafts, and patient survival.

[1]  MarkJ W McPhail,et al.  Liver transplantation for acute-on-chronic liver failure. , 2024, The lancet. Gastroenterology & hepatology.

[2]  Shivang Mehta,et al.  Policy corner: Cholangitis exception update. , 2023, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[3]  Chi-Chih Wang,et al.  Risk factors for pre‐transplantation bacteremia in adults with end‐stage liver disease: Effects on outcomes of liver transplantation , 2023, Clinical transplantation.

[4]  C. Féray,et al.  Liver transplant selection criteria and outcomes in critically ill patients with ACLF , 2023, JHEP reports : innovation in hepatology.

[5]  A. O'Brien,et al.  Antimicrobial prophylaxis in decompensated cirrhosis: friend or foe? , 2023, Hepatology communications.

[6]  C. Hsiao,et al.  Predictor of gram-negative bacteremia in cirrhotic patients with skin and soft-tissue infections , 2023, Medicine.

[7]  T. Gustot,et al.  Management of the acute on chronic liver failure in the intensive care unit. , 2023, Liver international : official journal of the International Association for the Study of the Liver.

[8]  P. Angeli,et al.  Impact of bacterial infections prior to liver transplantation on post-transplant outcomes in patients with cirrhosis , 2023, JHEP reports : innovation in hepatology.

[9]  A. Duseja,et al.  Burden, risk factors, and outcomes of multidrug-resistant bacterial colonisation at multiple sites in patients with cirrhosis , 2023, JHEP reports : innovation in hepatology.

[10]  M. Papp,et al.  EASL Clinical Practice Guidelines on acute-on-chronic liver failure. , 2023, Journal of hepatology.

[11]  R. Bhanji,et al.  Exception points for liver transplantation: A Canadian review. , 2022, Canadian liver journal.

[12]  M. Merli,et al.  Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections in Patients With Liver Cirrhosis. , 2022, Journal of clinical and experimental hepatology.

[13]  M. Hogardt,et al.  Rectal colonization by resistant bacteria increases the risk of infection by the colonizing strain in critically ill patients with cirrhosis. , 2022, Journal of hepatology.

[14]  R. Jalan,et al.  Cirrhosis-associated immune dysfunction , 2021, Nature Reviews Gastroenterology & Hepatology.

[15]  Javier Fernández,et al.  Management of bacterial and fungal infections in cirrhosis: The MDRO challenge. , 2021, Journal of hepatology.

[16]  G. Szabo,et al.  Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction. , 2021, Journal of hepatology.

[17]  S. Chokshi,et al.  The multifactorial mechanisms of bacterial infection in decompensated cirrhosis. , 2021, Journal of hepatology.

[18]  K. Reddy,et al.  The Evolving Challenge of Infections in Cirrhosis. , 2021, The New England journal of medicine.

[19]  R. Jalan,et al.  'Equity' and 'justice' for patients with acute-on chronic liver failure: A call to action. , 2021, Journal of hepatology.

[20]  A. McCullough,et al.  Trends and outcomes of infective endocarditis in cirrhosis: a propensity-matched national study , 2021, European journal of gastroenterology & hepatology.

[21]  C. O’Farrelly,et al.  Inflammatory processes in the liver: divergent roles in homeostasis and pathology , 2021, Cellular & Molecular Immunology.

[22]  R. Moreau,et al.  The Systemic Inflammation Hypothesis: Towards a New Paradigm of Acute Decompensation and Multiorgan Failure in Cirrhosis. , 2020, Journal of hepatology.

[23]  N. Mahmud,et al.  Patients with severe acute‐on‐chronic liver failure are disadvantaged by model for end‐stage liver disease‐based organ allocation policy , 2020, Alimentary pharmacology & therapeutics.

[24]  A. Frigo,et al.  Diagnostic and prognostic role of presepsin in patients with cirrhosis and bacterial infection , 2020, Clinical chemistry and laboratory medicine.

[25]  E. Seminari,et al.  Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  M. Ison,et al.  Pre‐ and post‐transplant bacterial infections in liver transplant recipients , 2019, Transplant infectious disease : an official journal of the Transplantation Society.

[27]  P. Angeli,et al.  Outcome of a First Episode of Bacterial Infection in Candidates for Liver Transplantation , 2019, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[28]  S. Abd-Elsalam,et al.  Impact of pre-transplant infection management on the outcome of living-donor liver transplantation in Egypt , 2019, Infection and drug resistance.

[29]  Douglas A. Simonetto,et al.  Management of Sepsis in Patients With Cirrhosis: Current Evidence and Practical Approach , 2019, Hepatology.

[30]  K. Reddy,et al.  Nosocomial Infections Are Frequent and Negatively Impact Outcomes in Hospitalized Patients With Cirrhosis. , 2019, The American journal of gastroenterology.

[31]  H. Van Vlierberghe,et al.  Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide. , 2019, Gastroenterology.

[32]  M. Senzolo,et al.  Outcome of critically ill cirrhotic patients admitted to the ICU: The role of ACLF. , 2019, Journal of hepatology.

[33]  A. de Gottardi,et al.  Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe. , 2019, Journal of hepatology.

[34]  J. Cadranel,et al.  Infectious endocarditis in the case of cirrhosis: where do we stand? , 2018, European journal of gastroenterology & hepatology.

[35]  J. Trebicka,et al.  Corrigendum to "EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis" [J Hepatol 69 (2018) 406-460]. , 2018, Journal of hepatology.

[36]  A. Lohse,et al.  Stabilisation of acute‐on‐chronic liver failure patients before liver transplantation predicts post‐transplant survival , 2018, Alimentary pharmacology & therapeutics.

[37]  R. Steadman,et al.  Potentially inappropriate liver transplantation in the era of the "sickest first" policy - A search for the upper limits. , 2017, Journal of hepatology.

[38]  S. Jaber,et al.  Liver transplantation in the most severely ill cirrhotic patients: A multicenter study in acute-on-chronic liver failure grade 3. , 2017, Journal of hepatology.

[39]  R. Jalan,et al.  Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis , 2017, Gut.

[40]  G. Boccia,et al.  Bacterial meningitis complicating the course of liver cirrhosis , 2017, Infection.

[41]  A. Burroughs,et al.  Bacterial Infections Change Natural History of Cirrhosis Irrespective of Liver Disease Severity , 2017, The American Journal of Gastroenterology.

[42]  Im-kyung Kim,et al.  Impact of Pre-Transplant Bacterial Infections on Post-Operative Outcomes in Patients after Liver Transplantation. , 2017, Surgical infections.

[43]  A. Cucchetti,et al.  Impact of preoperative infection on outcome after liver transplantation , 2017, The British journal of surgery.

[44]  Su Lin,et al.  Serum interleukin-6 in the diagnosis of bacterial infection in cirrhotic patients , 2016, Medicine.

[45]  Ming Chen,et al.  The role of the neutrophil Fcγ receptor I (CD64) index in diagnosing spontaneous bacterial peritonitis in cirrhotic patients. , 2016, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[46]  V. Mazzaferro,et al.  A Multistep, Consensus‐Based Approach to Organ Allocation in Liver Transplantation: Toward a “Blended Principle Model” , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[47]  A. Burroughs,et al.  C-reactive protein and bacterial infection in cirrhosis , 2014, Annals of gastroenterology.

[48]  J. Vincent,et al.  Impact of infection on the prognosis of critically ill cirrhotic patients: results from a large worldwide study , 2014, Liver international : official journal of the International Association for the Study of the Liver.

[49]  R. Moreau,et al.  Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. , 2013, Gastroenterology.

[50]  K. Reddy,et al.  Second infections independently increase mortality in hospitalized patients With cirrhosis: the north american consortium for the study of end‐stage liver disease (NACSELD) experience , 2012, Hepatology.

[51]  A. Burroughs,et al.  Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. , 2010, Gastroenterology.

[52]  S. Erlinger,et al.  European Association for the Study of the Liver , 2006 .